Companies/BE/ARGX

ARGENX SE

Last · Brussels€758.60+12.40 (+1.66%)live · yahoo · 5h ago
Vol 108.9K ≈ 82.58M
Market cap€47.7B62.9M sh
P/E · TTM32.5fwd 22.6 · eps 23.36
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
€568.40€925.00
Volume108.9Ksession

Issuer

Legal nameARGENX SE
HQBelgium (BE)
ListingBE ARGX
ISINNL0010832176
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyUSD
Entity registryisin:NL0010832176
Org IDARGX
Websiteargenx.com
Employees1,863
Addressargenx SE Laarderhoogtweg 25 1101 EB, Amsterdam +31 10 703 8441
Loading chart…

Upcoming earnings

1 event
5:40 PM UTC+2
Period
Sep 2026
Est. EPS
−$22.73
Est. revenue
1.6B
View upcoming earnings →

Press & signals

3 recent
  • GlobeNewswire

    argenx announces results of Extraordinary General Meeting of Shareholders and appointment of Thomas M. Brakel and Khurem Farooq as Non-Executive Directors

  • GlobeNewswire

    argenx to Present at Upcoming Investor Conferences

  • GlobeNewswire

    argenx Completes Acquisition of Forte Biosciences, Inc.

Documents

FormReporting forFiledFlags
annual reportargenx 2025 Integrated Annual Report.pdf.coredownload.inlineIR
—2025-12-31≈0
Showing 1 of 1 filings